American Century Companies’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,275,067
Closed -$127M 1606
2019
Q3
$127M Sell
1,275,067
-1,442,943
-53% -$137M 0.13% 208
2019
Q2
$251M Sell
2,718,010
-1,147,712
-30% -$109M 0.25% 115
2019
Q1
$365M Buy
3,865,722
+172,466
+5% +$15.1M 0.37% 64
2018
Q4
$237M Sell
3,693,256
-180,811
-5% -$13.3M 0.27% 99
2018
Q3
$347M Buy
3,874,067
+124,912
+3% +$11M 0.34% 74
2018
Q2
$298M Sell
3,749,155
-574,623
-13% -$47.7M 0.3% 87
2018
Q1
$386M Buy
4,323,778
+258,561
+6% +$24.8M 0.39% 64
2017
Q4
$424M Sell
4,065,217
-2,426,433
-37% -$274M 0.42% 50
2017
Q3
$947M Buy
6,491,650
+9,517
+0.1% +$1.3M 0.96% 11
2017
Q2
$842M Sell
6,482,133
-81,658
-1% -$10M 0.87% 11
2017
Q1
$817M Buy
6,563,791
+276,089
+4% +$33M 0.85% 10
2016
Q4
$728M Buy
6,287,702
+339,497
+6% +$37.8M 0.78% 11
2016
Q3
$622M Buy
5,948,205
+268,968
+5% +$29.1M 0.68% 14
2016
Q2
$560M Buy
5,679,237
+488,176
+9% +$50.5M 0.64% 20
2016
Q1
$520M Buy
5,191,061
+190,009
+4% +$19.6M 0.61% 25
2015
Q4
$599M Sell
5,001,052
-499,123
-9% -$57.7M 0.7% 19
2015
Q3
$595M Buy
5,500,175
+74,069
+1% +$9.19M 0.73% 13
2015
Q2
$628M Buy
5,426,106
+314,187
+6% +$35.9M 0.71% 15
2015
Q1
$589M Buy
5,111,919
+698,507
+16% +$83.5M 0.66% 17
2014
Q4
$494M Sell
4,413,412
-76,678
-2% -$8.09M 0.56% 31
2014
Q3
$426M Buy
4,490,090
+566,860
+14% +$51.2M 0.5% 40
2014
Q2
$337M Buy
3,923,230
+265,830
+7% +$20.2M 0.38% 63
2014
Q1
$255M Sell
3,657,400
-141,208
-4% -$11.2M 0.3% 90
2013
Q4
$321M Sell
3,798,608
-897,556
-19% -$71M 0.38% 58
2013
Q3
$361M Buy
4,696,164
+244,210
+5% +$17.1M 0.45% 47
2013
Q2
$260M Buy
+4,451,954
New +$268M 0.34% 74

Other funds holding CELG

American Century Companies's CELG Position: Q4 2019 in Review

American Century Companies sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,275,067 shares — an estimated $127M sold.

American Century Companies first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $947M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • American Century Companies reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • American Century Companies sold 1,275,067 Celgene Corp shares in Q4 2019, an estimated $127M.
  • American Century Companies first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • American Century Companies's Celgene Corp position peaked at $947M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on American Century Companies's 13F filing for Q4 2019, filed 12 Feb 2020.